| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 05/19/2011 | US20110117125 Compositions and methods for the delivery of nucleic acids |
| 05/19/2011 | US20110117015 Diagnostic Agents Selective Against Metalloproteases |
| 05/18/2011 | EP2322180A1 Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
| 05/18/2011 | EP2321286A1 Substituted n-oxide pyrazine derivatives |
| 05/18/2011 | EP2321285A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 05/18/2011 | EP1192136B1 Oligomers and polymers of cyclic imino carboxylic acids |
| 05/18/2011 | CN102066342A Quinoxalinedione derivatives |
| 05/18/2011 | CN102065864A Therapeutic agent for inflammatory bowel disease |
| 05/18/2011 | CN102065863A Therapeutic agent for spinal canal stenosis |
| 05/18/2011 | CN102060790A Quinoxaline double N-oxide derivative ligand and application thereof to promotion on copper-catalyzed C-O coupling reaction |
| 05/18/2011 | CN102060789A Method for preparing 3, 6-dimethyl-2, 5-dipyrazinamide |
| 05/18/2011 | CN102060788A Method for preparing bi-pyrazinamide crystals |
| 05/18/2011 | CN102060787A Tetramethylpyrazine ferulate crystals for suppressing platelet aggregation and thrombosis and preparation method thereof |
| 05/18/2011 | CN102060639A Method for preparing nitrogen-containing heterocyclic olefin derivatives |
| 05/18/2011 | CN101632669B Method of using diketopiperazines and composition containing them |
| 05/17/2011 | US7943620 Anti-anginal compounds |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943178 Methods and compositions for delivering peptides |
| 05/12/2011 | WO2011055247A1 A synthetic cyclic dipeptide and a process thereof |
| 05/12/2011 | US20110112295 Tricyclic spacer systems for nonlinear optical devices |
| 05/12/2011 | US20110112114 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 05/12/2011 | US20110112104 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 05/12/2011 | US20110112100 Hepatitis C Virus Inhibitors |
| 05/12/2011 | US20110112098 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 05/11/2011 | EP2318379A1 Method for preparation of piperazindione derivates |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN102056902A Imidazolidine derivatives |
| 05/11/2011 | CN102050794A Quinoxalin derivative and organic LED (Light-Emitting Diode) containing same |
| 05/11/2011 | CN101468970B Nitrone compounds, preparation thereof and use thereof in pharmacy |
| 05/10/2011 | US7939685 Hydroxylation of β-dicarbonyls with zirconium catalysts |
| 05/05/2011 | WO2011052285A1 Novel compound, field-effective transistor, solar cell, method for producing said compound, field-effective transistor, and solar cell, composition for organic semiconductor layer, and composition for p-type semiconductor layer |
| 05/05/2011 | US20110107442 Treatment of Male Sexual Dysfunction |
| 05/05/2011 | US20110105752 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 05/05/2011 | US20110105719 Reactor for producing pharmaceutical particles in a precipitation process |
| 05/05/2011 | US20110105571 Opioid Receptor Antagonists |
| 05/05/2011 | US20110105532 Haloalkyl-substituted amides as insecticides and acaricides |
| 05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105474 Heterocyclic derivatives as hdac inhibitors |
| 05/05/2011 | US20110105391 Methods and Compositions for Delivering Peptides |
| 05/05/2011 | US20110105329 Substituted Quinolinones Having Herbicidal Action |
| 05/05/2011 | CA2778615A1 Methods of synthesis and purification of heteroaryl compounds |
| 05/04/2011 | EP2316974A1 Dark quenchers for donor-acceptor energy transfer |
| 05/04/2011 | EP2316828A1 Piperazine derivatives and their use as therapeutic agents |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/04/2011 | CN1968949B Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/04/2011 | CN102046610A Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 05/04/2011 | CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN101538249B Preparation method of tritium or deuterium-labeled cyadox |
| 05/03/2011 | US7935703 Piperazines and piperidines as Mglur5 potentiators |
| 05/03/2011 | CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 04/28/2011 | WO2011048153A1 Novel acylpiperazinones and their use as pharmaceuticals |
| 04/28/2011 | WO2011048032A1 Diazepam derivatives as modulators of chemokine receptors |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | US20110098310 Novel compounds, use and preparation thereof |
| 04/28/2011 | US20110098309 Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098282 New compounds |
| 04/28/2011 | US20110095282 Organic electroluminescent device comprising triazine derivatives |
| 04/28/2011 | CA2776914A1 Diazepan derivatives as modulators of chemokine receptors |
| 04/28/2011 | CA2774910A1 Novel acylpiperazinones and their use as pharmaceuticals |
| 04/27/2011 | EP2314576A1 Phenyl derivatives as PPAR agonists |
| 04/27/2011 | EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 04/27/2011 | EP2314298A1 Microparticles comprising diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
| 04/27/2011 | EP2313377A1 Method for stereoselective synthesis of bicyclic heterocyclene |
| 04/27/2011 | EP2313373A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 04/27/2011 | CN102036963A Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 04/27/2011 | CN102036961A Pyridines and pyrazines as inhibitors of PI3K |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932388 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
| 04/26/2011 | US7932255 Controlling cell proliferation |
| 04/26/2011 | CA2500952C Neurologically-active compounds |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046946A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 04/21/2011 | US20110092703 P2x4 receptor antagonist |
| 04/21/2011 | US20110092679 Dark Quenchers For Donor-Acceptor Energy Transfer |
| 04/21/2011 | US20110092518 Antifouling Compounds And Use Thereof |
| 04/20/2011 | EP2310359A1 Organic compounds |
| 04/20/2011 | EP2310356A1 Adamantyl diamide derivatives and uses of same |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | CN102026975A Piperazines as anti-obesity agents |
| 04/20/2011 | CN101602736B Synthesis method of quizalofop-p-ethyl |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928104 Enhances sensitivity to radiotherapy and chemotherapy; synergistic; hydrolysis of a 2-methoxyquinoline or 2-methoxyquinoxaline; cyclization of a N-phenyl phenylacrylamide; or condensation of an o-benzenediamine with a keto-ester; preferred oxalate salt; side effect reduction |
| 04/19/2011 | CA2578047C Phenylaminopyridines |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/14/2011 | WO2011044212A1 Modulators of g protein-coupled receptor 88 |
| 04/14/2011 | US20110087025 Method for producing 3-amidinophenylalanine derivatives |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086863 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086818 Methods, compositions, and kits for treating pain and pruritus |
| 04/13/2011 | EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 04/13/2011 | EP2307024A1 Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activity |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN102016061A Novel peptidase substrates |